Nova Laboratories to supply leukaemia drug across Europe
July 4, 2012Manufacturing and Production
‘Xaluprine’, a liquid form of childhood leukaemia drug Mercaptopurine, will be distributed to hospital pharmacies across Europe after being granted …
Sluggish growth forecast concerns ABPI
July 3, 2012Sales and Marketing ABPI, NHS, OHE, VBP, government
New forecasts suggest that spending on branded drugs may fall in real terms by 2015, leading the ABPI to call …
Wellcome Trust appoints UK chief scientific adviser
July 3, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UK government, Wellcome Trust
The director of the Wellcome Trust since 2003 Sir Mark Walport has been appointed to succeed Sir John Beddington as …
MPs warn of dementia delays
July 3, 2012Research and Development, Sales and Marketing APPG, Alzheimer's, dementia, government
Patients with dementia are facing huge delays in their diagnosis and treatment according to a group of MPs and peers. …
Scinopharm Taiwan to build injectable drug facility
July 3, 2012Manufacturing and Production CMO, HPAPI, R&D, Scinopharm Taiwan
Contract manufacturing organisation Scinopharm Taiwan has said it plans to invest around $37.6 million in a new high-potency active pharmaceutical …
ICON announces senior clinical and laboratory appointments
July 3, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ICON
ICON, provider of outsourced development services to the pharma, biotech and medical device industries has announced appointments to the senior …
RSA appoints new managing director for RSA Germany
July 3, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kristian Juergensen, appointment, recruitment firm, rsa
RSA, the life sciences recruitment specialist, has appointed Kristian Juergensen as its new managing director of RSA in Germany. Juergensen …
China sets out quality rules for pharma excipients
July 3, 2012Manufacturing and Production China, GMP, IPEC, manufacturing
China’s State Food & Drug Administration has published a draft regulation laying out a number of new measures for boosting …
Merck closes Cherokee Pharma plant
July 3, 2012Manufacturing and Production API, Cherokee Pharmaceuticals, Merck, manufacturing
Merck & Co has decided to close down part of a US plant operated by subsidiary Cherokee Pharmaceuticals after failing …
GSK to pay ‘unprecedented’ $3 billion fraud charge
July 3, 2012Business Services, Sales and Marketing Avandia, Bextra, GSK, Paxil, Wellbutrin, Witty
GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history. The charges relate to …
Strategic North makes two appointments
July 3, 2012Business Services, Medical Communications, Sales and Marketing Strategic North
Healthcare strategic marketing agency Strategic North has expanded its team with the appointments of Sandra Du Cross in the role …
FDA approves Astellas’ leaky bladder drug
July 3, 2012Sales and Marketing Astellas, FDA, Myrbetriq, bladder, urology
The FDA has approved Astellas’ new overactive bladder disorder drug Myrbetriq. Myrbetriq (mirabegron), the first drug in its class, works …
GSK and Theravance post COPD pill data
July 2, 2012Research and Development, Sales and Marketing COPD, GSK, LABA, LAMA, Theravance
GSK and partner Theravance have released new data for its combination COPD drug. Results from four late-stage trials suggest that …
Cmed Clinical Services launches new corporate brochure
July 2, 2012Research and Development
Cmed Clinical Services is a long-established, flexible CRO with offices in the UK, US and Romania offering project management, clinical …
Doctors’ union the BMA appoints new chairman
July 2, 2012Medical Communications, Research and Development, Sales and Marketing BMA, Dr Mark Porter, appointment
Dr Mark Porter, a consultant anaesthetist in Coventry, has been elected new chairman of the British Medical Association’s UK Council. …
John LaMattina: FDA tries to disavow role in higher hurdles for new drugs
July 2, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, Pfizer, US, discovery, drug
As evidenced by various blog posts that I have written over the past year (e.g., “Why Doesn’t the FDA Get …
EMA publishes updated diabetes guidelines
July 2, 2012Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda
The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …
Health Economics and Outcomes Research – What’s the Value?
July 2, 2012Medical Communications HEOR, clinical evidence, economic evidence, market access, value
Pricing pressure and regulatory restrictions across various healthcare industries have called for more detailed evidence of outcomes
AstraZeneca and BMS buy Amylin for $7 billion
July 2, 2012Sales and Marketing Amylin, AstraZeneca, BMS
AstraZeneca and Bristol-Myers Squibb have struck a deal to purchase diabetes specialist Amylin in a complicated agreement worth $7 billion. …
Measuring Return on Investment of Health Economics and Outcomes Research through the Cloud
July 2, 2012Medical Communications HEOR, ROI, interactive tools, market access
Health economics and outcomes research (HEOR) is a young and fascinating area of research with an engaged academic community. Methodology …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
